BioCentury
ARTICLE | Clinical News

Takecab vonoprazan fumarate regulatory update

February 2, 2015 8:00 AM UTC

Takeda said Japan approved an NDA for Takecab vonoprazan fumarate to treat acid-related diseases, including gastric ulcer, duodenal ulcer and reflux esophagitis. It is also approved as an adjunct to H...